Eye and Behcet's disease

I Ksiaa, N. Abroug,M. Kechida,S. Zina, B. Jelliti, S. Khochtali,S. Attia,M. Khairallah

Journal Français d'Ophtalmologie(2019)

引用 42|浏览35
暂无评分
摘要
Behcet's disease is a chronic multisystem disorder characterized by relapsing inflammation for which the underlying histopathology is an occlusive vasculitis. The disease has a high prevalence in the Mediterranean region, Far and Middle Eastern countries. It is clinically characterized by oral and genital ulcerations, ocular inflammatory involvement, skin lesions, vascular involvement and numerous other systemic manifestations. Uveitis is by far the most common ocular manifestation of Behcet's disease. It typically presents in the form of relapsing-remitting panuveitis with retinal vasculitis that may result in severe visual loss. Management of Behcet's uveitis relies on corticosteroid therapy, conventional immunosuppressive drugs and biological agents and requires a close collaboration between ophthalmologist and internist. A better understanding of the auto-inflammatory process and of the role of cytokines implicated in the pathogenesis of Behcet's disease will enable researchers to develop more specific and effective therapy. (C) 2019 Elsevier Masson SAS. All rights reserved.
更多
查看译文
关键词
Behçet's disease,Uveitis,Retinal vasculitis,Blindness,Corticosteroids,Immunosuppressants,Biologics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要